Loading…

Role of NADPH Oxidase in Retinal Vascular Inflammation

In another study, it was demonstrated that NADPH oxidase-derived reactive oxygen species (ROS) are important for ischemia-induced increases in vascular endothelial growth factor (VEGF) and retinal neovascularization. Diabetes-induced increases in retinal ROS, VEGF expression, and vascular permeabili...

Full description

Saved in:
Bibliographic Details
Published in:Investigative ophthalmology & visual science 2008-07, Vol.49 (7), p.3239-3244
Main Authors: Al-Shabrawey, Mohamed, Rojas, Modesto, Sanders, Tammy, Behzadian, Ali, El-Remessy, Azza, Bartoli, Manuela, Parpia, Abdul Kader, Liou, Gregory, Caldwell, Ruth B
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-bd7e0496e343138d313a5d8dab83de02170686cfd30fea763256567b6fbd062b3
cites
container_end_page 3244
container_issue 7
container_start_page 3239
container_title Investigative ophthalmology & visual science
container_volume 49
creator Al-Shabrawey, Mohamed
Rojas, Modesto
Sanders, Tammy
Behzadian, Ali
El-Remessy, Azza
Bartoli, Manuela
Parpia, Abdul Kader
Liou, Gregory
Caldwell, Ruth B
description In another study, it was demonstrated that NADPH oxidase-derived reactive oxygen species (ROS) are important for ischemia-induced increases in vascular endothelial growth factor (VEGF) and retinal neovascularization. Diabetes-induced increases in retinal ROS, VEGF expression, and vascular permeability are accompanied by increases in the NADPH oxidase catalytic subunit NOX2 within the retinal vessels. The goal of this study was to evaluate the potential role of NOX2 and NADPH oxidase activity in the development of retinal vascular inflammation. Studies were performed in wild-type mice, mice lacking NOX2, and mice treated with the NADPH oxidase inhibitor apocynin in models of endotoxemia and streptozotocin-induced diabetes. Intracellular adhesion molecule (ICAM)-1 expression was determined by Western blot analysis. Leukocyte adhesion was assessed by labeling adherent leukocytes with concanavalin A. Vascular permeability was assessed by extravasation of FITC-conjugated albumin. ROS production was determined by dichlorofluorescein imaging. Both endotoxemia- and diabetes-induced increases in ICAM-1 expression and leukostasis were significantly inhibited by deletion of NOX2, indicating that this enzyme is critically involved in both conditions. Moreover, apocynin treatment and deletion of NOX2 were equally effective in preventing diabetes-induced increases in ICAM-1, leukostasis, and breakdown of the blood-retinal barrier, suggesting that NOX2 is primarily responsible for these early signs of diabetic retinopathy. These data suggest that NOX2 activity has a primary role in retinal vascular inflammation during acute and chronic conditions associated with retinal vascular inflammatory reactions. Targeting this enzyme could be a novel therapeutic strategy for treatment of the retinopathies associated with vascular inflammation.
doi_str_mv 10.1167/iovs.08-1755
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3798055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69255180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-bd7e0496e343138d313a5d8dab83de02170686cfd30fea763256567b6fbd062b3</originalsourceid><addsrcrecordid>eNpVkE1P3DAQhi3UChbKjTPKpT0ROv52LkiIfoCESoXaXq1J7LBGTkztLNv--2bFCuhl5jCP3nn1EHJE4ZRSpT-G9FhOwdRUS7lDFlRKVktt-BuyACpUDQLEHtkv5R6AUcpgl-xRw7WRWiyIuk3RV6mvvp1_-n5Z3fwJDouvwljd-imMGKtfWLpVxFxdjX3EYcAppPEdedtjLP5wuw_Izy-ff1xc1tc3X68uzq_rTgg-1a3THkSjPBeccuPmgdIZh63hzs91NCijut5x6D1qxZlUUulW9a0DxVp-QM6ech9W7eBd58cpY7QPOQyY_9qEwf5_GcPS3qVHy3VjQMo54MM2IKffK18mO4TS-Rhx9GlVrGqYlNTADJ48gV1OpWTfPz-hYDei7Ua0BWM3omf8-HWxF3hrdgbeb4HZH8Y-49iF8swxEEoxxl4KLsPdch2yt2XAGOdYatfrtWistpzxhv8D-YKTTw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69255180</pqid></control><display><type>article</type><title>Role of NADPH Oxidase in Retinal Vascular Inflammation</title><source>NCBI_PubMed Central(免费)</source><creator>Al-Shabrawey, Mohamed ; Rojas, Modesto ; Sanders, Tammy ; Behzadian, Ali ; El-Remessy, Azza ; Bartoli, Manuela ; Parpia, Abdul Kader ; Liou, Gregory ; Caldwell, Ruth B</creator><creatorcontrib>Al-Shabrawey, Mohamed ; Rojas, Modesto ; Sanders, Tammy ; Behzadian, Ali ; El-Remessy, Azza ; Bartoli, Manuela ; Parpia, Abdul Kader ; Liou, Gregory ; Caldwell, Ruth B</creatorcontrib><description>In another study, it was demonstrated that NADPH oxidase-derived reactive oxygen species (ROS) are important for ischemia-induced increases in vascular endothelial growth factor (VEGF) and retinal neovascularization. Diabetes-induced increases in retinal ROS, VEGF expression, and vascular permeability are accompanied by increases in the NADPH oxidase catalytic subunit NOX2 within the retinal vessels. The goal of this study was to evaluate the potential role of NOX2 and NADPH oxidase activity in the development of retinal vascular inflammation. Studies were performed in wild-type mice, mice lacking NOX2, and mice treated with the NADPH oxidase inhibitor apocynin in models of endotoxemia and streptozotocin-induced diabetes. Intracellular adhesion molecule (ICAM)-1 expression was determined by Western blot analysis. Leukocyte adhesion was assessed by labeling adherent leukocytes with concanavalin A. Vascular permeability was assessed by extravasation of FITC-conjugated albumin. ROS production was determined by dichlorofluorescein imaging. Both endotoxemia- and diabetes-induced increases in ICAM-1 expression and leukostasis were significantly inhibited by deletion of NOX2, indicating that this enzyme is critically involved in both conditions. Moreover, apocynin treatment and deletion of NOX2 were equally effective in preventing diabetes-induced increases in ICAM-1, leukostasis, and breakdown of the blood-retinal barrier, suggesting that NOX2 is primarily responsible for these early signs of diabetic retinopathy. These data suggest that NOX2 activity has a primary role in retinal vascular inflammation during acute and chronic conditions associated with retinal vascular inflammatory reactions. Targeting this enzyme could be a novel therapeutic strategy for treatment of the retinopathies associated with vascular inflammation.</description><identifier>ISSN: 0146-0404</identifier><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.08-1755</identifier><identifier>PMID: 18378574</identifier><identifier>CODEN: IOVSDA</identifier><language>eng</language><publisher>Rockville, MD: ARVO</publisher><subject>Acetophenones - pharmacology ; Animals ; Biological and medical sciences ; Blood-Retinal Barrier - drug effects ; Cell Adhesion - drug effects ; Diabetes Mellitus, Experimental - metabolism ; Diabetes Mellitus, Experimental - physiopathology ; Diabetic Retinopathy - complications ; Down-Regulation ; Endotoxemia - complications ; Endotoxemia - metabolism ; Enzyme Inhibitors - pharmacology ; Eye and associated structures. Visual pathways and centers. Vision ; Fundamental and applied biological sciences. Psychology ; Intercellular Adhesion Molecule-1 - metabolism ; Leukocytes - drug effects ; Leukostasis - etiology ; Leukostasis - prevention &amp; control ; Lipopolysaccharides - pharmacology ; Medical sciences ; Membrane Glycoproteins - deficiency ; Membrane Glycoproteins - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; NADPH Oxidase 2 ; NADPH Oxidases - antagonists &amp; inhibitors ; NADPH Oxidases - deficiency ; NADPH Oxidases - metabolism ; Ophthalmology ; Reactive Oxygen Species - metabolism ; Retinal Diseases - etiology ; Retinal Diseases - metabolism ; Retinal Vessels - metabolism ; Up-Regulation ; Vasculitis - etiology ; Vasculitis - metabolism ; Vertebrates: nervous system and sense organs</subject><ispartof>Investigative ophthalmology &amp; visual science, 2008-07, Vol.49 (7), p.3239-3244</ispartof><rights>2008 INIST-CNRS</rights><rights>Copyright © Association for Research in Vision and Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-bd7e0496e343138d313a5d8dab83de02170686cfd30fea763256567b6fbd062b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798055/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798055/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20466222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18378574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Sanders, Tammy</creatorcontrib><creatorcontrib>Behzadian, Ali</creatorcontrib><creatorcontrib>El-Remessy, Azza</creatorcontrib><creatorcontrib>Bartoli, Manuela</creatorcontrib><creatorcontrib>Parpia, Abdul Kader</creatorcontrib><creatorcontrib>Liou, Gregory</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><title>Role of NADPH Oxidase in Retinal Vascular Inflammation</title><title>Investigative ophthalmology &amp; visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>In another study, it was demonstrated that NADPH oxidase-derived reactive oxygen species (ROS) are important for ischemia-induced increases in vascular endothelial growth factor (VEGF) and retinal neovascularization. Diabetes-induced increases in retinal ROS, VEGF expression, and vascular permeability are accompanied by increases in the NADPH oxidase catalytic subunit NOX2 within the retinal vessels. The goal of this study was to evaluate the potential role of NOX2 and NADPH oxidase activity in the development of retinal vascular inflammation. Studies were performed in wild-type mice, mice lacking NOX2, and mice treated with the NADPH oxidase inhibitor apocynin in models of endotoxemia and streptozotocin-induced diabetes. Intracellular adhesion molecule (ICAM)-1 expression was determined by Western blot analysis. Leukocyte adhesion was assessed by labeling adherent leukocytes with concanavalin A. Vascular permeability was assessed by extravasation of FITC-conjugated albumin. ROS production was determined by dichlorofluorescein imaging. Both endotoxemia- and diabetes-induced increases in ICAM-1 expression and leukostasis were significantly inhibited by deletion of NOX2, indicating that this enzyme is critically involved in both conditions. Moreover, apocynin treatment and deletion of NOX2 were equally effective in preventing diabetes-induced increases in ICAM-1, leukostasis, and breakdown of the blood-retinal barrier, suggesting that NOX2 is primarily responsible for these early signs of diabetic retinopathy. These data suggest that NOX2 activity has a primary role in retinal vascular inflammation during acute and chronic conditions associated with retinal vascular inflammatory reactions. Targeting this enzyme could be a novel therapeutic strategy for treatment of the retinopathies associated with vascular inflammation.</description><subject>Acetophenones - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood-Retinal Barrier - drug effects</subject><subject>Cell Adhesion - drug effects</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Diabetes Mellitus, Experimental - physiopathology</subject><subject>Diabetic Retinopathy - complications</subject><subject>Down-Regulation</subject><subject>Endotoxemia - complications</subject><subject>Endotoxemia - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Eye and associated structures. Visual pathways and centers. Vision</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Intercellular Adhesion Molecule-1 - metabolism</subject><subject>Leukocytes - drug effects</subject><subject>Leukostasis - etiology</subject><subject>Leukostasis - prevention &amp; control</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - deficiency</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>NADPH Oxidase 2</subject><subject>NADPH Oxidases - antagonists &amp; inhibitors</subject><subject>NADPH Oxidases - deficiency</subject><subject>NADPH Oxidases - metabolism</subject><subject>Ophthalmology</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Retinal Diseases - etiology</subject><subject>Retinal Diseases - metabolism</subject><subject>Retinal Vessels - metabolism</subject><subject>Up-Regulation</subject><subject>Vasculitis - etiology</subject><subject>Vasculitis - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0146-0404</issn><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkE1P3DAQhi3UChbKjTPKpT0ROv52LkiIfoCESoXaXq1J7LBGTkztLNv--2bFCuhl5jCP3nn1EHJE4ZRSpT-G9FhOwdRUS7lDFlRKVktt-BuyACpUDQLEHtkv5R6AUcpgl-xRw7WRWiyIuk3RV6mvvp1_-n5Z3fwJDouvwljd-imMGKtfWLpVxFxdjX3EYcAppPEdedtjLP5wuw_Izy-ff1xc1tc3X68uzq_rTgg-1a3THkSjPBeccuPmgdIZh63hzs91NCijut5x6D1qxZlUUulW9a0DxVp-QM6ech9W7eBd58cpY7QPOQyY_9qEwf5_GcPS3qVHy3VjQMo54MM2IKffK18mO4TS-Rhx9GlVrGqYlNTADJ48gV1OpWTfPz-hYDei7Ua0BWM3omf8-HWxF3hrdgbeb4HZH8Y-49iF8swxEEoxxl4KLsPdch2yt2XAGOdYatfrtWistpzxhv8D-YKTTw</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Al-Shabrawey, Mohamed</creator><creator>Rojas, Modesto</creator><creator>Sanders, Tammy</creator><creator>Behzadian, Ali</creator><creator>El-Remessy, Azza</creator><creator>Bartoli, Manuela</creator><creator>Parpia, Abdul Kader</creator><creator>Liou, Gregory</creator><creator>Caldwell, Ruth B</creator><general>ARVO</general><general>Association for Research in Vision and Ophtalmology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080701</creationdate><title>Role of NADPH Oxidase in Retinal Vascular Inflammation</title><author>Al-Shabrawey, Mohamed ; Rojas, Modesto ; Sanders, Tammy ; Behzadian, Ali ; El-Remessy, Azza ; Bartoli, Manuela ; Parpia, Abdul Kader ; Liou, Gregory ; Caldwell, Ruth B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-bd7e0496e343138d313a5d8dab83de02170686cfd30fea763256567b6fbd062b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acetophenones - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood-Retinal Barrier - drug effects</topic><topic>Cell Adhesion - drug effects</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Diabetes Mellitus, Experimental - physiopathology</topic><topic>Diabetic Retinopathy - complications</topic><topic>Down-Regulation</topic><topic>Endotoxemia - complications</topic><topic>Endotoxemia - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Eye and associated structures. Visual pathways and centers. Vision</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Intercellular Adhesion Molecule-1 - metabolism</topic><topic>Leukocytes - drug effects</topic><topic>Leukostasis - etiology</topic><topic>Leukostasis - prevention &amp; control</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - deficiency</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>NADPH Oxidase 2</topic><topic>NADPH Oxidases - antagonists &amp; inhibitors</topic><topic>NADPH Oxidases - deficiency</topic><topic>NADPH Oxidases - metabolism</topic><topic>Ophthalmology</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Retinal Diseases - etiology</topic><topic>Retinal Diseases - metabolism</topic><topic>Retinal Vessels - metabolism</topic><topic>Up-Regulation</topic><topic>Vasculitis - etiology</topic><topic>Vasculitis - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Shabrawey, Mohamed</creatorcontrib><creatorcontrib>Rojas, Modesto</creatorcontrib><creatorcontrib>Sanders, Tammy</creatorcontrib><creatorcontrib>Behzadian, Ali</creatorcontrib><creatorcontrib>El-Remessy, Azza</creatorcontrib><creatorcontrib>Bartoli, Manuela</creatorcontrib><creatorcontrib>Parpia, Abdul Kader</creatorcontrib><creatorcontrib>Liou, Gregory</creatorcontrib><creatorcontrib>Caldwell, Ruth B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Investigative ophthalmology &amp; visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Shabrawey, Mohamed</au><au>Rojas, Modesto</au><au>Sanders, Tammy</au><au>Behzadian, Ali</au><au>El-Remessy, Azza</au><au>Bartoli, Manuela</au><au>Parpia, Abdul Kader</au><au>Liou, Gregory</au><au>Caldwell, Ruth B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of NADPH Oxidase in Retinal Vascular Inflammation</atitle><jtitle>Investigative ophthalmology &amp; visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>49</volume><issue>7</issue><spage>3239</spage><epage>3244</epage><pages>3239-3244</pages><issn>0146-0404</issn><issn>1552-5783</issn><eissn>1552-5783</eissn><coden>IOVSDA</coden><abstract>In another study, it was demonstrated that NADPH oxidase-derived reactive oxygen species (ROS) are important for ischemia-induced increases in vascular endothelial growth factor (VEGF) and retinal neovascularization. Diabetes-induced increases in retinal ROS, VEGF expression, and vascular permeability are accompanied by increases in the NADPH oxidase catalytic subunit NOX2 within the retinal vessels. The goal of this study was to evaluate the potential role of NOX2 and NADPH oxidase activity in the development of retinal vascular inflammation. Studies were performed in wild-type mice, mice lacking NOX2, and mice treated with the NADPH oxidase inhibitor apocynin in models of endotoxemia and streptozotocin-induced diabetes. Intracellular adhesion molecule (ICAM)-1 expression was determined by Western blot analysis. Leukocyte adhesion was assessed by labeling adherent leukocytes with concanavalin A. Vascular permeability was assessed by extravasation of FITC-conjugated albumin. ROS production was determined by dichlorofluorescein imaging. Both endotoxemia- and diabetes-induced increases in ICAM-1 expression and leukostasis were significantly inhibited by deletion of NOX2, indicating that this enzyme is critically involved in both conditions. Moreover, apocynin treatment and deletion of NOX2 were equally effective in preventing diabetes-induced increases in ICAM-1, leukostasis, and breakdown of the blood-retinal barrier, suggesting that NOX2 is primarily responsible for these early signs of diabetic retinopathy. These data suggest that NOX2 activity has a primary role in retinal vascular inflammation during acute and chronic conditions associated with retinal vascular inflammatory reactions. Targeting this enzyme could be a novel therapeutic strategy for treatment of the retinopathies associated with vascular inflammation.</abstract><cop>Rockville, MD</cop><pub>ARVO</pub><pmid>18378574</pmid><doi>10.1167/iovs.08-1755</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0146-0404
ispartof Investigative ophthalmology & visual science, 2008-07, Vol.49 (7), p.3239-3244
issn 0146-0404
1552-5783
1552-5783
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3798055
source NCBI_PubMed Central(免费)
subjects Acetophenones - pharmacology
Animals
Biological and medical sciences
Blood-Retinal Barrier - drug effects
Cell Adhesion - drug effects
Diabetes Mellitus, Experimental - metabolism
Diabetes Mellitus, Experimental - physiopathology
Diabetic Retinopathy - complications
Down-Regulation
Endotoxemia - complications
Endotoxemia - metabolism
Enzyme Inhibitors - pharmacology
Eye and associated structures. Visual pathways and centers. Vision
Fundamental and applied biological sciences. Psychology
Intercellular Adhesion Molecule-1 - metabolism
Leukocytes - drug effects
Leukostasis - etiology
Leukostasis - prevention & control
Lipopolysaccharides - pharmacology
Medical sciences
Membrane Glycoproteins - deficiency
Membrane Glycoproteins - metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
NADPH Oxidase 2
NADPH Oxidases - antagonists & inhibitors
NADPH Oxidases - deficiency
NADPH Oxidases - metabolism
Ophthalmology
Reactive Oxygen Species - metabolism
Retinal Diseases - etiology
Retinal Diseases - metabolism
Retinal Vessels - metabolism
Up-Regulation
Vasculitis - etiology
Vasculitis - metabolism
Vertebrates: nervous system and sense organs
title Role of NADPH Oxidase in Retinal Vascular Inflammation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A57%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20NADPH%20Oxidase%20in%20Retinal%20Vascular%20Inflammation&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Al-Shabrawey,%20Mohamed&rft.date=2008-07-01&rft.volume=49&rft.issue=7&rft.spage=3239&rft.epage=3244&rft.pages=3239-3244&rft.issn=0146-0404&rft.eissn=1552-5783&rft.coden=IOVSDA&rft_id=info:doi/10.1167/iovs.08-1755&rft_dat=%3Cproquest_pubme%3E69255180%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-bd7e0496e343138d313a5d8dab83de02170686cfd30fea763256567b6fbd062b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69255180&rft_id=info:pmid/18378574&rfr_iscdi=true